General
Preferred name
CEFPROZIL
Synonyms
Cefprozil monohydrate ()
Cefprozil hydrate ()
Cefprozil hydrate (Cefzil) ()
Cefprozil (monohydrate) ()
Cefprozil e-form ()
NSC-759099 ()
Cefprozil, e-isomer ()
Cefprozilo ()
Cefzil ()
Cefprozil, (e)-isomer ()
CEFPROZIL, (E)- ()
CEFPROZIL ANHYDROUS, (E)- ()
Cefprozil-d4 ()
P&D ID
PD013063
CAS
92676-86-3
92665-29-7
121123-17-9
1426173-48-9
Tags
available
drug
Approved by
FDA
First approval
1991
Drug indication
osteomyelitis
Bacterial infection
Drug Status
approved
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
13
AdooQ Bioactive Compound Library
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
48
Properties
(calculated by RDKit )
Molecular Weight
389.1
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
4
Rotatable Bonds
5
Ring Count
3
Aromatic Ring Count
1
cLogP
0.71
TPSA
132.96
Fraction CSP3
0.28
Chiral centers
3.0
Largest ring
6.0
QED
0.55
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
MOA
Antibacterial
bacterial cell wall synthesis inhibitor
Pathway
Microbiology&virology
Anti-infection
Target
PBPs
antibiotic
Bacterial
Disease Area
otolaryngology, infectious disease, pulmonary
Indication
pharyngitis, tonsillitis, otitis, sinusitis, respiratory tract infections, skin infections, bronchitis
Therapeutic Class
Antibiotics
Source data

